<DOC>
	<DOC>NCT02193581</DOC>
	<brief_summary>The use of MDS to access the presence of melanoma in the skin.</brief_summary>
	<brief_title>Non-invasive Melanoma Assessment Using a Topical Fluorescence Reagent and Optical Imaging</brief_title>
	<detailed_description>A topical agent is applied to suspicious skin lesions and imaged. The images are analyzed to provide a score that correlates with the probability for the presence of melanoma in the lesion.</detailed_description>
	<mesh_term>Melanoma</mesh_term>
	<criteria>Individuals with skin lesion with one or more of the ABCDE features and recommended for a skin biopsy. The lesion is accessible to the imaging device, with at least 1 cm of skin around the lesion that is accessible to the MDS. Male and female â‰¥ 21 years old. Subject is capable of giving written informed consent. Primary excision. The lesion is less than 1 cm from the eyes. The lesion is on the palms of hands or soles of the feet. Mucosal lesion. Pregnant females. Low study procedure compliance. Patients who are mentally or physically unable to comply with all aspects of the study. Undergoing chemotherapy. Minor or legally incompetent and not able to sign the consent form. Patient previously tested by MDS and was diagnosed with melanoma during the study. Sensitivity to fluorescein</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>